SEC Form 4 · accession 0001144204-18-062413
INTERCEPT PHARMACEUTICALS, INC. · ICPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christian Weyer
Officer — EVP, Research & Development
Period of report
Nov 27, 2018
Accepted (ET)
Nov 29, 2018 · 7:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001270073
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 27, 2018 | F | 1,438 | $108.66 | D | 17,162 | D | |
| Common Stock | Nov 29, 2018 | S | 1,343 | $113.78 | D | 15,819 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock.
- F2This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
Remarks
Exhibit 24.1 - Power of Attorney